Send to a Friend Font Size: Increase Decrease

VIR and ALPMY Related Headlines

Feb 23, 2026 05:00PM Astellas and Vir Biotechnology Announce Global Strategic Collaboration to Advance PSMA-targeting PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer

VIR and ALPMY Related Press Releases

Feb 23, 2026 05:00PM Astellas and Vir Biotechnology Announce Global Strategic Collaboration to Advance PSMA-targeting PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer

VIR and ALPMY Related SEC Filings